SCHEMBL34468469

SCHEMBL34468469

COc1ccc2cc(C3(O)CC3)ccc2c1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.48
CYP2A6 P11509 1/20 0.48
LMNA P02545 1/20 0.46
OPRM1 P35372 3/20 0.44
OPRD1 P41143 3/20 0.44
OPRK1 P41145 3/20 0.44
OPRL1 P41146 3/20 0.44
KDM4E B2RXH2 1/20 0.44
HSD17B1 P14061 1/20 0.43
HSD17B2 P37059 1/20 0.43
ALDH1A1 P00352 2/20 0.43
MEN1 O00255 1/20 0.42
POLB P06746 1/20 0.42
MAPK1 P28482 1/20 0.42
KMT2A Q03164 1/20 0.42
PTGS1 P23219 1/20 0.41
AKR1C3 P42330 1/20 0.41
AKR1C2 P52895 1/20 0.41
ABCB11 O95342 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1628516 0.93 CYP1A2 (0.46) CYP1A2CYP2A6LMNAOPRM1OPRD1
SCHEMBL6730322 0.89 DRD2 (0.47) CYP1A2CYP2A6LMNAOPRM1OPRD1
SCHEMBL19737304 0.87 LMNA (0.47) CYP1A2CYP2A6LMNAOPRM1OPRD1
SCHEMBL8395305 0.86 HTR1A (0.50) CYP1A2CYP2A6LMNAOPRM1OPRD1
SCHEMBL2241718 0.82 ALDH1A1 (0.40) CYP1A2CYP2A6LMNAOPRM1OPRD1
SCHEMBL28299186 0.82 OPRM1 (0.58) LMNAOPRM1OPRD1OPRK1OPRL1
SCHEMBL6408821 0.81 OPRM1 (0.41) OPRM1OPRK1OPRL1ALDH1A1MEN1
SCHEMBL12477851 0.79 LMNA (0.51) CYP1A2CYP2A6LMNAOPRM1OPRL1
SCHEMBL31557718 0.79 OPRM1 (0.64) OPRM1OPRD1OPRK1OPRL1ALDH1A1
SCHEMBL7968189 0.78 KMT2A (0.65) LMNAOPRM1OPRL1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260118361-A1 FLUOROGENIC BIOCONJUGATION OF CYCLOPROPANOL-BASED FLUOROPHORES FOR BIOLOGICAL APPLICATIONS UNIV SOUTH CAROLINA (US) 2026-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260118361-A1 FLUOROGENIC BIOCONJUGATION OF CYCLOPROPANOL-BASED FLUOROPHORES FOR BIOLOGICAL APPLICATIONS QSOX1, CBR1, CBR3 CYP1A2 895/4885CYP2A6 1724/4885LMNA 3895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.